Pasireotide-LAR in acromegaly patients treated with a combination therapy: a real-life study

Purpose: Little data are available regarding the safety and efficacy of s witching to Pasireotide-LAR monotherapy in acromegaly patients with partial resistance to first-generation somatostatin agonists (1gSRL) who require combination treatment with cabergoline or pegvisomant. Method: In this mono...

Full description

Bibliographic Details
Main Authors: Hélène Lasolle, Amandine Ferriere, Alexandre Vasiljevic, Sandrine Eimer, Marie-Laure Nunes, Antoine Tabarin
Format: Article
Language:English
Published: Bioscientifica 2019-10-01
Series:Endocrine Connections
Subjects:
Online Access:https://ec.bioscientifica.com/view/journals/ec/8/10/EC-19-0332.xml